SG11202012567PA - Using power loss density and related measures to quantify the dose of tumor treating fields (ttfields) - Google Patents

Using power loss density and related measures to quantify the dose of tumor treating fields (ttfields)

Info

Publication number
SG11202012567PA
SG11202012567PA SG11202012567PA SG11202012567PA SG11202012567PA SG 11202012567P A SG11202012567P A SG 11202012567PA SG 11202012567P A SG11202012567P A SG 11202012567PA SG 11202012567P A SG11202012567P A SG 11202012567PA SG 11202012567P A SG11202012567P A SG 11202012567PA
Authority
SG
Singapore
Prior art keywords
ttfields
quantify
dose
power loss
loss density
Prior art date
Application number
SG11202012567PA
Inventor
Zeev Bomzon
Hadas Sara Hershkovich
Ariel Naveh
Shay Levi
Noa Urman
Original Assignee
Novocure Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novocure Gmbh filed Critical Novocure Gmbh
Publication of SG11202012567PA publication Critical patent/SG11202012567PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36002—Cancer treatment, e.g. tumour
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/06—Electrodes for high-frequency therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/3603—Control systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Developmental Disabilities (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Electrotherapy Devices (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
SG11202012567PA 2018-07-18 2019-07-18 Using power loss density and related measures to quantify the dose of tumor treating fields (ttfields) SG11202012567PA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862700080P 2018-07-18 2018-07-18
US201862754901P 2018-11-02 2018-11-02
US201962833983P 2019-04-15 2019-04-15
PCT/IB2019/056181 WO2020016840A1 (en) 2018-07-18 2019-07-18 Using power loss density and related measures to quantify the dose of tumor treating fields (ttfields)

Publications (1)

Publication Number Publication Date
SG11202012567PA true SG11202012567PA (en) 2021-01-28

Family

ID=68051832

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202012567PA SG11202012567PA (en) 2018-07-18 2019-07-18 Using power loss density and related measures to quantify the dose of tumor treating fields (ttfields)

Country Status (12)

Country Link
US (1) US11911612B2 (en)
EP (3) EP3967362A1 (en)
JP (2) JP7267393B2 (en)
KR (2) KR102607603B1 (en)
CN (1) CN112601578A (en)
AU (1) AU2019305159B2 (en)
BR (1) BR112020025269A2 (en)
CA (1) CA3103075A1 (en)
IL (1) IL279253A (en)
MX (1) MX2020013431A (en)
SG (1) SG11202012567PA (en)
WO (1) WO2020016840A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10779875B2 (en) 2013-05-06 2020-09-22 Novocure Gmbh Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment
US10188851B2 (en) 2015-10-28 2019-01-29 Novocure Limited TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements
US10821283B2 (en) 2016-04-04 2020-11-03 Novocure Gmbh Reducing motility of cancer cells using tumor treating fields (TTFields)
JP6980706B2 (en) 2016-06-30 2021-12-15 ノボキュア ゲーエムベーハー Array for longitudinal transmission of tumor treatment electric field to the body
EP3571503A1 (en) 2017-01-19 2019-11-27 Moshe Giladi System for viewing cell cultures under a microscope whilst applying ttfields
KR20210030971A (en) 2018-07-10 2021-03-18 노보큐어 게엠베하 Suppression of viral infection using an alternating electric field
WO2020049482A1 (en) 2018-09-07 2020-03-12 Yaniv Alon Treating autoimmune diseases using an alternating electric field to reduce the proliferation of t-cells
US11986647B2 (en) 2018-09-07 2024-05-21 Novocure Gmbh Treating autoinflammatory and mitochondrial diseases using an alternating electric field
WO2020079554A1 (en) 2018-10-15 2020-04-23 Zeev Bomzon Generating tumor treating fields (ttfields) with high uniformity throughout the brain
JP7148722B2 (en) 2018-10-25 2022-10-05 ゼーヴ・ボンゾン Delivery of an alternating electric field (e.g., TTField) to the spinal structures of a subject
EP4019080A1 (en) 2018-11-19 2022-06-29 Novocure GmbH Arrays for delivering tumor treating fields (ttfields) with selectively addressable sub-elements
BR112021004336A2 (en) 2018-11-29 2021-08-17 Novocure Gmbh transducer arrays with improved flexibility to deliver ttfields (tumor treatment fields)
EP3968279A1 (en) 2019-01-08 2022-03-16 Novocure GmbH Evaluating quality of segmentation of an image into different types of tissue for planning treatment using tumor treating fields (ttfields)
WO2020174403A1 (en) 2019-02-26 2020-09-03 Moshe Giladi Determining a frequency for ttfields treatment based on an electrical characteristic of targeted cancer cells
JP2022522936A (en) 2019-02-27 2022-04-21 ノボキュア ゲーエムベーハー Delivery of Tumor Treatment Electric Field (TTFIELDS) Using Implantable Transducer Array
JP7419391B2 (en) 2019-03-29 2024-01-22 ノボキュア ゲーエムベーハー Method for restoring sensitivity to TTFields in TTFields-resistant cancer cells by PTGER3 inhibitors
ES2940749T3 (en) 2019-04-17 2023-05-11 Novocure Gmbh Load data from an isolated system without compromising isolation
JP7472264B2 (en) 2019-07-31 2024-04-22 ノボキュア ゲーエムベーハー Application of tumor-treating electric fields (TT fields) via electrodes embedded in skull implants
JP2022545794A (en) 2019-08-30 2022-10-31 ノボキュア ゲーエムベーハー Application of tumor therapeutic fields (TTFields) to the neck
MX2022006136A (en) 2019-12-31 2022-06-17 Novocure Gmbh Arrays for delivering tumor treating fields (ttfields) with individually accessible electrode elements and temperature sensors.
WO2021137085A2 (en) 2019-12-31 2021-07-08 Novocure Gmbh High voltage, high efficiency sine wave generator that prevents spikes during amplitude adjustments and switching of channels
KR102464313B1 (en) * 2020-05-18 2022-11-08 주식회사 필드큐어 Apparatus and Method for Quality Assurance in Electric Field Therapy
US11818943B2 (en) 2020-06-25 2023-11-14 Novocure Gmbh Fabricating organic light emitting diodes (OLEDs) using tubulin
CN117425514A (en) 2021-03-18 2024-01-19 诺沃库勒有限责任公司 Construction of 3D models with liquid hydrogels
KR102562095B1 (en) * 2021-06-14 2023-08-02 주식회사 필드큐어 Method and System for Optimizing Electrode Array Structure in Electrotherapy
WO2024052877A1 (en) 2022-09-08 2024-03-14 Novocure Gmbh Constructing a 3d phantom with a matrix material having conductive particles dispersed therein

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8175698B2 (en) 2000-02-17 2012-05-08 Novocure Ltd. Treating bacteria with electric fields
US7089054B2 (en) 2002-10-02 2006-08-08 Standen Ltd. Apparatus and method for treating a tumor or the like
US7599746B2 (en) 2000-02-17 2009-10-06 Standen Ltd Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases
US7146210B2 (en) 2000-02-17 2006-12-05 Standen Ltd. Apparatus and method for optimizing tumor treatment efficiency by electric fields
US8447395B2 (en) 2000-02-17 2013-05-21 Novocure Ltd Treating bacteria with electric fields
US6868289B2 (en) 2002-10-02 2005-03-15 Standen Ltd. Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor
US7016725B2 (en) 2001-11-06 2006-03-21 Standen Ltd. Method and apparatus for destroying dividing cells
US7136699B2 (en) 2002-10-02 2006-11-14 Standen, Ltd. Apparatus for destroying dividing cells
JP5280600B2 (en) 2000-02-17 2013-09-04 パルティ、ヨーラム Method and apparatus for destroying dividing cells
US6546290B1 (en) 2000-04-12 2003-04-08 Roamitron Holding S.A. Method and apparatus for electromedical therapy
JP4750784B2 (en) 2004-04-23 2011-08-17 ノヴォキュアー・リミテッド Treatment of tumors by electric fields of different frequencies
EP2345451B1 (en) 2004-12-07 2018-01-24 Novocure Limited Electrodes for applying an electric field in-vivo over an extended period of time
EP1833554A2 (en) 2004-12-27 2007-09-19 Standen Ltd. Treating a tumor or the like with electric fields at different orientations
US20160055304A1 (en) * 2005-06-16 2016-02-25 Aaken Laboratories Targeted electrical stimulation
PT3804809T (en) 2005-10-03 2024-03-07 Novocure Gmbh Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
US8019414B2 (en) 2006-04-05 2011-09-13 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
DK2167194T3 (en) 2007-03-06 2017-06-19 Novocure Ltd TREATMENT OF CANCER USING ELECTROMAGNETIC FIELDS IN COMBINATION WITH PHOTODYNAMIC THERAPY
WO2009022225A1 (en) 2007-08-14 2009-02-19 Novocure Ltd. Treating parasites with electric fields
US8715203B2 (en) 2007-09-17 2014-05-06 Novocure Limited Composite electrode
EP2488251A4 (en) * 2009-10-16 2014-02-19 Virginia Tech Intell Prop Treatment planning for electroporation-based therapies
US10779875B2 (en) 2013-05-06 2020-09-22 Novocure Gmbh Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment
US9655669B2 (en) 2013-05-06 2017-05-23 Novocure Limited Optimizing treatment using TTFields by changing the frequency during the course of long term tumor treatment
EP3294127A1 (en) * 2015-05-12 2018-03-21 Navix International Limited Systems and methods for tracking an intrabody catheter
US9910453B2 (en) 2015-09-25 2018-03-06 Novocure Limited High voltage, high efficiency sine wave generator with pre-set frequency and adjustable amplitude
US10188851B2 (en) * 2015-10-28 2019-01-29 Novocure Limited TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements
US10821283B2 (en) 2016-04-04 2020-11-03 Novocure Gmbh Reducing motility of cancer cells using tumor treating fields (TTFields)
JP6980706B2 (en) 2016-06-30 2021-12-15 ノボキュア ゲーエムベーハー Array for longitudinal transmission of tumor treatment electric field to the body
US20180008708A1 (en) 2016-07-10 2018-01-11 Novocure Limited Synchronizing Tumor Cells to the G2/M Phase Using TTFields Combined with Taxane or Other Anti-Microtubule Agents
AU2017313423B2 (en) 2016-08-18 2022-01-13 Novocure Gmbh Temperature measurement in arrays for delivering ttfields
JP7184774B2 (en) 2016-12-13 2022-12-06 ノボキュア ゲーエムベーハー Treat a patient with a TT field with electrode positions optimized using a deformable template
EP3571503A1 (en) 2017-01-19 2019-11-27 Moshe Giladi System for viewing cell cultures under a microscope whilst applying ttfields
US10953209B2 (en) 2018-03-28 2021-03-23 Board Of Regents Of The University Of Texas System Treating tumors using TTFields combined with a PARP inhibitor
CN112566665A (en) 2018-04-09 2021-03-26 莫舍·吉拉迪 Treatment of tumors with TTfields and Aurora kinase inhibitors
CN112424626A (en) 2018-04-10 2021-02-26 吉夫·波姆桑 Low frequency (< 1 MHz) AC conductivity estimates derived from two MRI images with different repetition times
CN116173401A (en) 2018-07-03 2023-05-30 埃德温·阊 Enhancement of cell membrane permeability using alternating electric fields
KR20210030971A (en) 2018-07-10 2021-03-18 노보큐어 게엠베하 Suppression of viral infection using an alternating electric field
US11179322B2 (en) 2018-07-10 2021-11-23 Novocure Gmbh Methods and compositions for treating tumors with TTFields and sorafenib

Also Published As

Publication number Publication date
NZ770869A (en) 2023-11-24
CA3103075A1 (en) 2020-01-23
EP3967362A1 (en) 2022-03-16
CN112601578A (en) 2021-04-02
EP3967361A1 (en) 2022-03-16
AU2019305159B2 (en) 2022-07-14
JP2022511225A (en) 2022-01-31
KR20210034620A (en) 2021-03-30
WO2020016840A1 (en) 2020-01-23
JP7267393B2 (en) 2023-05-01
IL279253A (en) 2021-01-31
KR102607603B1 (en) 2023-11-29
EP3823715A1 (en) 2021-05-26
JP2023100700A (en) 2023-07-19
BR112020025269A2 (en) 2021-03-09
US20200023179A1 (en) 2020-01-23
US11911612B2 (en) 2024-02-27
AU2019305159A1 (en) 2021-01-07
JP7448709B2 (en) 2024-03-12
KR20230161546A (en) 2023-11-27
MX2020013431A (en) 2021-05-27

Similar Documents

Publication Publication Date Title
IL279253A (en) Using power loss density and related measures to quantify the dose of tumor treating fields (ttfields)
PT3439733T (en) Reducing motility of cancer cells using tumor treating fields (ttfields)
PL4066887T3 (en) Devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
IL287643A (en) Compositions and methods for the treatment of cancer using a tet2 engineered t cell therapy
IL268138A (en) Combinations of cabozantinib and atezolizumab to treat cancer
GB201719076D0 (en) Particles for the treatment of cancer in combination with radiotherapy
IL259121A (en) Long-lived gadolinium based tumor targeted imaging and therapy agents
EP4021559C0 (en) Delivering tumor treating fields (ttfields) to the neck
IL282836A (en) 5-halouracil-modified micrornas and their use in the treatment of cancer
HK1231560A1 (en) Predictive method of characterizing the radiosensitivity and tissular reaction of a patient to therapeutic ionizing radiation
IL247859B (en) Methods of identifiying a tumor that is sensetive to treatment with axitinib, and axitinib for use for treating cancer
IL254842A0 (en) Therapeutic compositions and methods of use for treating cancer
SG10201908584SA (en) Fixed Dose Combinations And Formulations Comprising ETC1002 And One Or More Statins And Methods Of Treating Or Reducing The Risk Of Cardiovascular Disease
HK1245096A1 (en) Cell therapeutic agent for cancer treatment and combination therapy with same
IL275517A (en) Methods and combination therapy to treat cancer
MX2019008233A (en) Targeted doxorubicin-gold nanoconjugates for tumor therapy.
IL286334A (en) Modified micrornas and their use in the treatment of cancer
IL280060A (en) Methods of treating cancer with tnf expressing myxoma virus
IL279591A (en) Methods of treating cancer using combination therapy
IL280726A (en) Treatment of b cell malignancies
IL280000A (en) Tumor reduction formulations and methods of use thereof
IL290321A (en) Use of sepiapterin and metabolites thereof to treat radiation exposure
IL263394A (en) Methods of activating dysfunctional immune cells and treatment of cancer
FR3017624B1 (en) PREDICTIVE METHOD FOR CHARACTERIZING THE RADIOSENSITIVITY AND TISSUE REACTION OF A PATIENT TO THERAPEUTIC IONIZING RADIATION
IL275913A (en) Methods and combination therapy to treat cancer